На главную
Результаты поиска “Fosamax in trial for bone cancer”
Say No to Bisphosphonates
Say No to Bisphosphonates Bisphosphonates cause a systemic subclinical toxicity which may erupt as osteonecrosis. Bisphosphonates are structural analogues to calcium pyrophosphate in bone and bind to calcium in the skeleton. The bisphosphonates story illustrates the ills of medicine: Useless and improper treatment, and false interpretation of clinical trials. Bisphosphonates are a class of drugs that prevent the loss of bone density, used to treat osteoporosis and similar diseases Bisphosphonates have become an important treatment for the palliation of metastatic bone disease. Their increasing use has lead to the recognition of toxicities that can lead to substantial morbidity for the patient with advanced cancer. This case presentation highlights toxicities associated with bisphosphonate use and provides some guidelines on the use of bisphosphonates and management of these toxicities. The most important predisposing factors for development of bisphosphonate-associated ONJ are the type and total dose of bisphosphonate (potency) and a history of trauma, dental surgery, or dental infection in the jaw. There is a strong association with jaw trauma such as dental extractions
Просмотров: 443 Gershom Zajicek M.D,
The Role of Bisphosphonates in Breast Cancer Treatment
Much-anticipated and highly-disappointing results were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. In an international trial of 3,360 women, the bone-building drug Zometa, failed to prevent breast cancer recurrence and found no disease-free survival benefit among the majority of women with Stage II/III disease. Bisphosphonates role in the treatment of breast cancer has been an active area of research focus, as previous clinical trials had shown that the class of drugs may have anti-cancer activity. Sharon Giordano, M.D., associate professor in MD Anderson's Department of Breast Medical Oncology, was a commentator on the press program shares her perspective
Просмотров: 1375 MD Anderson Cancer Center
Bisphosphonates vs. RANK ligand inhibition in bone metastases
Dr. Corey Langer chairs this 18th Annual "Perspectives in Thoracic Oncology" meeting which is captured in its entirety in this webcast. An expert faculty covers every aspect of lung cancer management including exciting new screening and staging modalities, management approaches, and emerging treatment options. Earn accreditation for this activity at the following location: http://elc.imedex.com/elc/activity-search.aspx?search=6940 © 2013 Imedex, LLC.
Просмотров: 1434 ImedexCME
Fosamax Lawsuit News: Fosamax Lawsuit Against Merck Declared a Mistrial
Visit http://www.fosamaxlawsuitscenter.com if you suffered injuries from Fosamax for more information. The first trial to consider claims that drug maker Merck hid the alleged bone-weakening, femur-fracturing side effects of Fosamax ended abruptly this week after plaintiff Christina Su, 67, suffered a heart attack, forcing New Jersey Superior Court Judge Carol Higbee to declare a mistrial. The trial began on March 12. There are more than 3,000 state and federal trials pending in which plaintiffs allege they suffered either jaw necrosis or femur fractures. The Rottenstein Law Group represents clients in Fosamax trials and encourages people to visit the firm's Fosamax website at www.fosamaxlawsuitscenter.com. Rottenstein Law Group, LLP 321 W 44th St # 804 New York, NY 10036 (212) 933-9500 http://www.youtube.com/watch?v=Rj7yShNS0FU
Просмотров: 2888 RotlawNewsDesk
ECCO-ESMO: Bone Drug Blocks Cancer Return
STOCKHOLM -- Postmenopausal women with early breast cancer had significant improvement in disease-free survival when treated with the bone-targeted drug zoledronic acid, updated results from a large randomized trial showed. Medpage Today: http://medpagetoday.com Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ Latest medical news: http://www.medpagetoday.com/latest/ The MedPage Today app: iOS: https://goo.gl/JKrkHq Android: https://play.google.com/store/apps/details?id=com.medpagetoday.medpage MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday Medpage Today on Facebook: https://www.facebook.com/MedPageToday
Просмотров: 87 MedPage Today
Dr. Robert Bunning on the Rare Side Effects of Bisphosphonates
The FDA recently launched new hearings on the safety of bisphosphonates -- medications commonly used to treat osteoporosis. MedStar NRH physician Dr. Robert Bunning participated in those hearings and spoke to WUSA'-TV CBS 9 News in Washington, DC about his testimony and the latest from those hearings. Learn more about our hospital: http://ow.ly/MsNQe Learn more about Dr. Bunning: http://ow.ly/MsNKm Aired September 12, 2011.
Просмотров: 526 MedStar National Rehabilitation Network
Preventing Fractures in Osteoporosis
Fragility fractures are common in postmenopausal women with osteoporosis; treatment has focused on increasing bone formation and decreasing bone resorption to reduce risk. New research findings are summarized in this short video. Full study: http://nej.md/2xRSopg Full Quick Take video archive: http://nej.md/quick-take
Просмотров: 2759 NEJMvideo
The risk of skeletal adverse events with zoledronic acid
Heinz Ludwig, MD, from the Wilhelminen Cancer Research Institute, Vienna, Austria, discusses two promising studies presented at the 2017 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France. The first investigated the combination of zoledronic acid and denusomab (NCT01345019). The results found that zoledronic acid reduced the risk of skeletal related adverse events, however there was a decreased risk of progression. The second study, the Cardamom trial (NCT02315716) investigated the combination of carfilzomib, cyclophosphamide, and dexamethasone. Dr Ludwig states that although not every trial shows successful results, they do offer new information.
FDA Update: Bisphosphonates liek Fosamax and Femur Fractures
Information from the FDA on the possible link between extended bisphosphonate use (osteoporosis medications like fosamax and Boniva) and femur fractures (broken thighbones). more information and attorneys available at www.my-fosamax-lawsuit.com.
Просмотров: 3303 FosamaxAttorneys
Faslodex AVI
Просмотров: 1088 Aponogeton Ap
How Safe are Bisphosphonates?
The bisphosphonates are a well-known family of medications used to cure osteoporosis and atrial fibrillation. The following drugs are all in the bisphosphonate family: Fosamax, Actonel, Boniva, and Reclast. These medications are all very similar with some variations. Recently, these drugs have been reported to have caused severe health problems to its users. FDA is now undergoing thorough evaluation and investigation on these drugs. For more information, visit http:www.hummerlaw.com or you can also call at 1-800-433-8420.
Просмотров: 940 chuckrightontop
Paget's Disease - A case prepared by Prof.  Saleh Al-Awdhaly
An interesting Case of an elderly man with history of Hypertension, abnormal gait, visual abnormities and severe bone pain. Hyperdynamic Circulation. It could be Paget's.
Просмотров: 72 Prof. Saleh Mohammed Al-Awdhaly
Fosamax And Warnings- Serious Side Effects
Please Visit http://defectivedrugsettlements.com/bone-density-drug-submission It may seem strange to think that a drug designed to improve bone strength could cause death of the bone in the jaw, and bone fractures but that is exactly what is happening. Patients have relied on these medication to help prevent osteoporosis, pagets disease and various other conditions for many years. Many doctors have turned to the bisphosphonates family of drugs to maintain bone strength in women,treat pagets disease and help in the aid to some cancer victims. But a serious side effect common with this drug are bones that have become weak and brittle, and break . Another more serious side effect known as dead jaw disease. If you or a loved on has suffered, our attorneys are offering a free no obligation consultation to discuss your legal rights, compensation for your pain suffering and medical bills .
Просмотров: 1993 Robert Martin
fosamax medicine
fosamax side effect fosamax and fossamax and osteoporosis fosamax solution side effects of stopping fosamax intake what is the drug fosamax food drug interaction of fosamax dead jaw fosamax osteoporosis fosamax fosamax dental clinical trials fosamax fatigue
Просмотров: 232 matthiasmasoneusa
SABCS: More Evidence that Bisphosphonates Prevent Breast Cancer
http://www.medpagetoday.com SAN ANTONIO -- Women taking the osteoporosis drug zoledronic acid had a 30% to 35% lower risk of breast cancer, according to data from two different retrospective studies. Medpage Today: http://medpagetoday.com Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ Latest medical news: http://www.medpagetoday.com/latest/ The MedPage Today app: iOS: https://goo.gl/JKrkHq Android: https://play.google.com/store/apps/details?id=com.medpagetoday.medpage MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday Medpage Today on Facebook: https://www.facebook.com/MedPageToday
Просмотров: 116 MedPage Today
BlazerCast 11/20/07
Learn how research at UAB is giving osteoporosis patients more choices in their battle against bone disease in the BlazerCast for 11/20/07
Просмотров: 282 University of Alabama at Birmingham
Todrick’s Leukemia Battle Includes Bone Marrow Transplant from Moffitt and Memorial
In his battle with leukemia, Todrick received a bone marrow transplant at Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System. He benefited from a haploidentical transplant, a new process that does not require a complete donor match. Yehuda Deutsch, MD, hematologist-oncologist, and Hugo Fernandez, MD, Chair and Medical Director of Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System, led his care team. Learn more about how Moffitt and Memorial are stronger together for patients with blood disorders at MHS.net/Moffitt. To learn more about Dr. Yehuda Deutsch, visit his physician profile page at https://www.mhs.net/physicians/d/deutsch-yehuda-e. To learn more about Dr. Hugo Fernandez, visit his physician profile page at https://www.mhs.net/physicians/f/fernandez-hugo-f.
Просмотров: 620 Memorial Healthcare System
Prof. Robert E. Coleman: Can bisphosphonates act as anti-cancer drugs?
The first BMJD Congress in Barcelona, Spain, January 19-22, 2012 (http://www.congressmed.com/bmjd). Inverview with Prof. Robert E. Coleman, University of Sheffield: Bone metastasis is a common problem with poor specific treatments. However, can symptoms be alleviated to provide a better quality of life?
Просмотров: 171 BMJDCongress
FDA Update- Fosamax and Femur Fractures
If you have taken Fosamax and have experienced: Femur/ Thigh Bone Break Femur fractures (thigh bone fractures), or Osteonecrosis of the Jaw (dead jaw) call Potts Law Firm, 1-866-311-2230. Fosamax is the most popular osteoporosis drug on the market, but recent studies have uncovered a defect in the medication. Many who have taken Fosamax are suffering low-impact femur fractures—breaks of the thigh bone that occur due to falls from standing height or less. It turned out that rather than strengthen bones, Fosamax causes them to become brittle and to break under modest stress.
Просмотров: 322 pottslawfirm
Osteoporosis Treatments
Osteoporosis Treatments. Osteoporosis Features. 1.Osteoporosis is a condition in which your bones separate speedier than they regrow. 2.Treatment for the most part incorporates a mix of drugs and way of life changes. 3.The most forceful approach to anticipate bone misfortune is to take professionally prescribed drugs. Bones in your body are living tissues that continually separate and supplant themselves with new material. Osteoporosis is a condition in which your bones separate speedier than they regrow. This makes them turn out to be less thick, more permeable, and more fragile. This debilitates your bones and can prompt more cracks and breaks. No cure is accessible. The objective of treatment is to secure and reinforce your bones. Treatment normally incorporates a mix of pharmaceuticals and way of life changes to help moderate the rate of bone reabsorption by the body. Causes and hazard factors. A great many people have their most elevated bone mass and thickness when they're in their mid 20s. As you age, you lose old bone at a speedier rate than your body can supplant it. Along these lines, more seasoned individuals are at a higher hazard for osteoporosis. Ladies likewise have a higher danger of creating osteoporosis since they normally have more slender bones than men. Estrogen ensures bones. Ladies who are experiencing menopause encounter a reduction in estrogen levels, which prompts fragile bones. Different dangers factors include: *smoking. *certain prescriptions, for example, steroids, proton pump inhibitors, and barbiturates. *malnutrition. *certain ailments, for example, rheumatoid joint inflammation, numerous myeloma. Osteoporosis solutions. The most forceful approach to counteract bone misfortune is to take doctor prescribed solutions, for example, the accompanying: Bisphosphonates. These are the most widely recognized osteoporosis sedate medications. They incorporate the accompanying. *Alendronate (Fosamax) is an oral prescription individuals ordinarily take once every week. *Ibandronate (Boniva) is accessible as a month to month oral tablet or as an intravenous infusion that you get four times each year. *Risedronate (Actonel) is accessible in every day, week by week, every other month, or month to month measurements. *Zoledronic corrosive (Reclast) is accessible as an intravenous implantation that you get once every maybe a couple years. The symptoms of these medications can incorporate indigestion, queasiness, and stomach torment. Now and again, they can cause bone harm in the jaw, or jaw osteonecrosis. This symptom is uncommon and happens all the more regularly in individuals who take high measurements of bisphosphonates. Antibodies. Denosumab (Xgeva, Prolia) is a counter acting agent. It connects to a protein engaged with your body's procedure of bone reabsorption. This counter acting agent moderates bone reabsorption. It additionally keeps up bone thickness. It's accessible as an infusion that you get like clockwork. The reactions can include: *skin bothering. *muscle solidness. *pain. *spasms. *fatigue. *excessive sweating. *bone cracks in uncommon cases. Hormone treatment. . Osteoporosis Complications,Complications of Osteoporosis,free calcium,prevent osteoporosis naturally,Оsteoporosis Symptoms,osteoporosis treatment,osteoporosis exercises,osteoporosis surgery,osteoporosis workout,osteoporosis and arthritis,osteoporosis and osteopenia,osteoporosis arthritis treatment,osteoporosis cure,osteoporosis cause,osteoporosis cure naturally,osteoporosis diet,osteoporosis definition,osteoporosis diagnosis and treatment,osteoporosis All Photos Licensed Under CC Source : www.pexels.com www.pixabay.com www.commons.wikimedia.org
Просмотров: 2112 Beauty & Health Tips
Defective Drugs Lawyer: Fosamax Injury Claims Information May 2011 Newsletter
http://www.aronfeld.com/lawyer-attorney-1742219.html Florida Fosamax injury claim lawyer Spencer Aronfeld discuss Fosamax claims for fractures and osteonecrosis. Fosamax is a prescription drug used by women to treat osteoporosis. Also announces Lawyers to the Rescue's upcoming town hall meeting regarding bullying. For more information call: 866-597-4529 or 305-441-0440 Visit: http://www.aronfeld.com/ Facebook: https://www.facebook.com/spencer.aronfeld?v=wall Twitter: http://twitter.com/aronfeld Linkedin: http://www.linkedin.com/in/aronfeld
Просмотров: 307 Aronfeld Trial Lawyers
Bisphosphonate Use in Breast Cancer
In this segment, Sara Hurvitz, MD; Hope Rugo, MD; Dialecti Voudouris, MD; and Eleftherios Mamounas, MD, examine the use of bisphosphonates in breast cancer.
Просмотров: 452 OncLiveTV
Treating Osteoporosis in High-Risk Elderly
Dr. Barbara Messinger-Rapport describes the clinical and financial implications of treatment with the monoclonal antibody denosumab for high-risk elders and/or patients who are unable to tolerate bisphosphonate treatment.
DC Fosamax Lawyer | Fosamax Attorney in DC | Peter Biberstein
Visit us at: http://pricebenowitz.com/dc-injury/fosamax-lawyer DC Personal Injury Lawyer Peter Biberstein discusses important information about the drug Fosamax. Fosamax is used for the treatment of Osteoporosis. However, the risks associated with this drug far outweigh the benefits. Biberstein discusses some of these risks, such as esophageal ulcers, Stevens-Johnson syndrome, Uveitis, and Osteonecrosis of the jaw. If you or a loved one has experienced personal injury or death as a result of the drug Fosamax, you may be entitled to compensation. Contact an experienced DC Fosamax lawyer today to help you . It often happens that a drug is pushed onto the market before the full scope of its effects are known. This is because pharmaceutical companies are driven by profits, and will not always release full information about a drug that they are aware is harmful. Clinical trials do not always show all of the effects of a drug, and pharmaceutical companies will sometimes submit drugs to the Food and Drug Administration without proper testing or alter test results in their favor. Unfortunately, this means that many people who take the drug might experience unanticipated consequences. You trust your doctor, pharmaceutical companies, and your pharmacist to provide you with a safe drug that will benefit you. When this trust is breached, legal action can be taken. A DC Fosamax Lawyer can help you prepare a case and fight for your right to be compensated for personal injury resulting from the drug Fosamax. A number of damages can result from personal injuries involving drug use. Depending on how severe your personal injury is, medical costs may be a great burden. The risks of Fosamax are very severe –many of the resulting conditions may lead to death if not treated properly. Furthermore, injuries sustained in these cases may prevent someone from working, which could cause them to lose significant future earnings that they would have otherwise received. Filing a claim against the pharmaceutical company that distributes Fosamax gives you the chance to receive compensation for all of these medical costs. In addition, pain and suffering are damages incurred in these types of cases. Not only can physical pain result from resulting conditions, but emotional pain and humiliation can result as well. The drug companies responsible for these damages should be held accountable. When you file a personal injury claim, you will most likely be up against the at-fault party’s insurance company. An experienced DC Fosamax lawyer can inform you of the best ways to handle this situation. These companies might, for instance, pressure you to give a recorded statement about the incident or try to persuade you to settle quickly. These are not the only routes you can take in these cases, and your lawyer can help determine the best way to deal with your individual case. A DC Fosamax lawyer can also help to prepare your case by gathering evidence, interviewing witnesses, and collecting and reviewing your medical records. If you or a loved one has been a victim of personal injury or death resulting from Fosamax, contact experienced personal injury lawyer Peter Biberstein on his website, or call us at (202) 600-9400. Price Benowitz LLP 409 7th St NW #100 Washington, DC 20004 (202) 600-9400 http://pricebenowitz.com/dc-injury/ We welcome you to subscribe to the Price Benowitz channel: https://www.youtube.com/channel/UCtZQJnzqIZpg4LxkN5eUcXA?sub_confirmation=1 *Please note that laws change. This information is accurate as of the date this video was published and is not to be construed as legal advice. To find out how your prospective case applies to current law give us a call today. This Video is Related to the Following Terms: DC Fosomax Lawyer, DC Fosomax Attorney, Fosomax Lawyer in DC, Fosomax Attorney in DC, DC Fosomax Lawyers, DC Fosomax Attorneys, Fosomax Lawyers in DC, Fosomax Attorneys in DC
Просмотров: 134 Price Benowitz LLP
Preventing Bone Mineral Loss | 2017 A Woman's Journey Bethesda with Swaytha Yalamarnchi, M.D.
Throughout our lives we are regenerating bone mass — losing old bone and making new bone—but by age 25, we lose more bone than we build. Learn what we can do to reduce our risk for fractures and bone loss, particularly when lifestyle changes alone are inadequate, from endocrinologist Swaytha Yalamanchi. Learn more at: http://www.hopkinsmedicine.org/awomansjourney
Просмотров: 299 Johns Hopkins Medicine
Treatment of Bisphosphonate Stress Fractures
by Dr Rekha Ganeshalingham Western Health, Melbourne, Australia
Просмотров: 302 Orthofracs
Parilman & Associates: Problems from taking FOSAMAX? 1.800.391.8000
If you or someone you know has suffered health problems from the defective drug Fosamax, call Parilman & Associates for the help you deserve. Parilman & Associates has qualified, experienced attorneys that provide nationwide representation.
Просмотров: 332 Parilman3918000
FDA Urges Caution Over Long-Term Use of Bone-Density-Building Drugs
Millions of women grapple with whether to take bone-density-building drugs to treat or prevent osteoporosis, but the FDA this week warned that long-term use of bisphosphonates can lead to rare fractures and side effects. Margaret Warner and Maine Medical Center's Dr. Clifford Rosen discuss the risks outlined by the FDA.
Просмотров: 3389 PBS NewsHour
Update on Risks of Osteoporosis Medications
Update on the risks of osteoporosis medications, featuring MedStar NRH physician Dr. Robert Bunning. This story originally aired on 9 News (CBS) in Washington, DC. Learn more about Orthopaedic Injuries service at MedStar NRH: http://ow.ly/OVSSJ Learn more about Dr. Robert Bunning: http://ow.ly/OVTjW
Просмотров: 302 MedStar National Rehabilitation Network
Prolia Side Effects
http://www.melioguide.com/free-course Prolia is a new osteoporosis medication that is experiencing strong acceptance. Is it right for you. I asked Kent MacLeod, Clinical Pharmacist at NutriChem to provide a balanced assessment of this treatment.
Просмотров: 15802 Margaret Martin
Fosamax Lawsuit. Nation's Leading Attorneys For ONJ Cases
www.FosamaxLawsuit.com 1-888-238-1998 We are the nation's leading legal team for litigation regarding Bisphosphonate Complications. We have formed a team of experienced lawyers that can represent you against the big drug companies FOSAMAX ®, AREDIA ®, ZOMETA ® and ACTONEL ® usage has been linked to the catastrophic condition "Dead Jaw" (ONJ - Osteonecrosis of the Jaw). If you or a loved one have taken any of these drugs for osteoporosis, cancer or multiple myeloma & you have experienced complications, you must act now! YOU MAY DESERVE COMPENSATION. FOR A FREE CONFIDENTIAL CASE EVALUATION, CONTACT US TODAY.
Просмотров: 1040 fosamaxlawsuit
Jaw Bone Necrosis
Fosamax, Actonel, Aredia, Zometa. Have you used them? The FDA links this class of drugs to the death of the jawbone. Only some patients are affected, so if youve been exposed, let your dental specialist know so they can watch out for osteonecrosis. Terrell Hogan is already seeking justice for victims of this terrible injury. If your jaw has been damaged, now is the time for action. Prescription drugs (bisphosphonates) linked to osteonecrosis of the jaw (Also known as "Dead Jaw", "BisPhossy Jaw" and "Jaw Necrosis"). Terrell Hogan is already prosecuting claims. Terrell Hogan is Jacksonville, Florida's largest personal injury trial law firm, experienced in over 25 practice areas including asbestos, mesothelioma, car accidents, trucking accidents, defective drugs, dog bites, Florida auto insurance, medical malpractice, wrongful death and unsafe products. We feel so strongly that everyone should have access to news about dangerous and defective products that we've included it on television as a service to the community. You may have seen or heard our alerts for the community about product recalls, and you can also find that information here on our website. Terrell Hogan believes that product recalls are worth repeating to help keep your family informed and safe.
Просмотров: 2815 Terrell Hogan
Dr. Tripathy Discusses Bisphosphonate Studies
Debu Tripathy, MD; Co-leader Women's Breast Cancer Program at USC/Norris Comprehensive Cancer Center Discusses Bisphosphonate Studies
Просмотров: 109 OncLiveTV
Cancer's a Bitch
Thank you for all your support, my mother has now passed and it is somewhat depressing when people leave comments on here thinking that she is still here. but i do appreciate it. a more recent video can be seen here: http://www.youtube.com/watch?v=4V5n4xbEvws and the most recent, announcing here passing, is here: http://www.youtube.com/watch?v=AzoTAgHoc5E My mother was first diagnosed with breast cancer was in 2001. After chemotherapy and Radiation treatments she was declared to be in remission. In 2006 her cancer returned, this time in her hip. after another round of chemotherapy and radiation she was, again, declared in remission. Late in 2007 more mets were found in her spine and elsewhere. She was diagnosed as having metastatic cancer, the chronic, incurable, version of the disease she already had. She was put on Aredia to help strengthen her bones and Falsodex which is meant to interfere with the metabolism of the cancer and help keep it from getting worse or spreading. Today, February 12, 2008, she was told that her cancer has spread even more. They are going to put her again on chemotherapy and/or radiation, whatever hey decide is best. in hopes of bringing it under control again. Hope and pray for my mother and everyone suffering with cancer. For a first hand account and better, more accurate information about what's happening with my mother visit her blog. http://ruthsmusings.blogspot.com/ Support cancer reasearch. The Susan G. Komen Foundation, http://www.komen.org/ does a lot of great work. As does The Breast Cancer Site, http://www.TheBreastCancerSite.com As my mother would say "Get your mammograms, do your self exams."
Просмотров: 1938 MattProvance
Osteo-K Helped Her Pain from Osteoporosis and Osteoarthritis
Watch Terry talk about how she tried Fosamax for her osteoporosis without benefit, how she was in pain from osteoporosis and osteoarthritis, and how Osteo-K decreased her pain and helped her become active again. www.nbihealth.com
Просмотров: 708 NBIHealth
Professor Rob Coleman explains landmark bisphosphonates results
Professor Rob Coleman, a leading oncologist and researcher based in Sheffield, explains his landmark results showing that bisphosphonate drugs significantly improve the chances of survival for post-menopausal women diagnosed with breast cancer.
Просмотров: 285 Breast Cancer Now
Prolia Treats Osteoporosis in Women After Menopause - Overview
http://www.rxwiki.com/prolia https://www.youtube.com/playlist?list=PLXxn_pCvHVm5rtYCS2sLMNQ2j1LWbE0_L Prolia, the brand name form of denosumab, is a prescription medicine used to treat osteoporosis in women after menopause who cannot take other osteoporosis medications. It is also used in people who have tried other osteoporosis medications without success, and in people who have bone loss caused by cancer treatments. Prolia belongs to a group of drugs called RANK ligand inhibitors. These work by slowing production and activity of osteoclasts, which are bone cells that cause bone breakdown. Prolia comes in an injectable form to be given just under the skin by a healthcare provider. Patients receiving Prolia should also take calcium and vitamin D supplements every day. Common side effects of Prolia include back pain, muscle pain, and pain in the arms and legs.
Просмотров: 3319 RxWikiTV
Accelerate Thinking Ep. 23 - The Bone Density Myth - Dr. John Bartemus
Have you been told you have Osteoporosis or Osteopenia? Are you taking a drug or calcium supplement to raise your bone density? Are you postmenopausal? If you answered yes to the last 2 of those, you are at high risk for breast cancer. Resources [i] J M Zmuda, J A Cauley, B M Ljung, D C Bauer, S R Cummings, L H Kuller,. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst. 2001 Jun 20;93(12):930-6. PMID: 11416114 [ii] Marjolein van der Klift, Chris E D H de Laet, Jan Willem W Coebergh, Albert Hofman, Huibert A P Pols,. Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone. 2003 Mar;32(3):211-6. PMID: 12667548 [iii] Ozgur Oktem, Mert Kucuk, Kamer Ozer, Devrim Sezen, Fatih Durmusoglu. Relation of body fat distribution to femoral neck bone density and endometrial thickness in postmenopausal women. Gynecol Endocrinol. 2010 Feb 23. Epub 2010 Feb 23. PMID: 20175708 [iv] P Hadji, M Gottschalk, V Ziller, M Kalder, C Jackisch, U Wagner. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT). Maturitas. 2007 Mar 20;56(3):312-21. Epub 2006 Oct 17. PMID: 17049767 [v] Tsutomu Douchi, Yukie Yonehara, Shoichiro Kosha, Ichiro Iwamoto, Yoshiaki Rai, Yoshiatsu Sagara, Yoshihisa Umekita. Bone mineral density in breast cancer patients with positive estrogen receptor tumor status. Maturitas. 2007 Jul 20;57(3):221-5. Epub 2007 Jan 19. PMID: 17240090 [vi] T V Nguyen, J R Center, J A Eisman. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas. 2000 Jul 31;36(1):27-34. PMID: 10989239 [vii] Carolyn J Crandall, Yan Zheng, Arun Karlamangla, Barbara Sternfeld, Laurel A Habel, Nina Oestreicher, Janet Johnston, Jane A Cauley, Gail A Greendale. The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol. 2007 Aug;17(8):575-83. Epub 2007 May 29. PMID: 17532645 [viii] O Ganry, B Tramier, P Fardellone, N Raverdy, A Dubreuil. High bone-mass density as a marker for breast cancer in post-menopausal women. Breast. 2001 Aug;10(4):313-7. PMID: 14965600 [ix] F L Lucas, J A Cauley, R A Stone, S R Cummings, M T Vogt, J L Weissfeld, L H Kuller. Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. Am J Epidemiol. 1998 Jul 1;148(1):22-9. PMID: 9663400 [x] J A Cauley, F L Lucas, L H Kuller, M T Vogt, W S Browner, S R Cummings. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA. 1996 Nov 6;276(17):1404-8. PMID: 8892715 [xi] O Ganry, C Baudoin, P Fardellone, J Peng, N Raverdy. Bone mass density and risk of breast cancer and survival in older women. Eur J Epidemiol. 2004;19(8):785-92. PMID: 15469036 [xii] Karin Sedó Sarkis, Marcelo de Medeiros Pinheiro, Vera Lúcia Szejnfeld, Lígia Araújo Martini. High bone density and bone health. Endocrinol Nutr. 2012 Mar ;59(3):207-14. Epub 2012 Feb 9. PMID: 22325788 [xiii] K O'Brien, B Caballero. High bone mass as a marker for breast cancer risk. Nutr Rev. 1997 Jul;55(7):284-6. PMID: 9279067 [xiv] World Life Expectancy, USA Cause of Death by Age and Gender Dr. John Bartemus Accelerate Chiropractic, PC 21000 Torrence Chapel Rd Suite 101 Cornelius, NC 28031 704-895-2240 DrJohn@AccelerateChiropractic.com http://www.AccelerateChiropractic.com
Просмотров: 2031 Dr. John Bartemus
Reclast  And Bisphosphonates Linked To Dead Jaw And Brittle Breaking Bones
Please visit http://defectivedrugsettlements.com/bone-density-drug-submission Leading medical injury attorneys are standing by for a free case review, of those affected by the side effects of these drugs. It may seem strange to think that a drug designed to improve bone strength could cause death of the bone in the jaw, and bone fractures but that is exactly what is happening. Contact us today to learn your legal rights, you are due compensation for your pain suffering and medical bills.
Просмотров: 1409 Robert Martin
Dr. Siegel on the Importance of Bisphosphonates
David S. Siegel, M.D., PH.D. Chief, Multiple Myeloma at John Theurer on the importance of bisphosphonates
Просмотров: 185 OncLiveTV
Is There a Connection Between Osteoporosis and Soda?
Proper diet is the key to healthy and strong bones. But, how sure you are that you're following a proper diet most especially when it comes to soda intake? Is there a Connection Between Osteoporosis and Soda? Read the rest of the article here - http://www.fosamaxfemurfracturelawsuit.com/updates/is-there-a-connection-between-osteoporosis-and-soda/. If you know someone who is currently taking Fosamax, check this link to learn more about its adverse side effects - http://www.fosamaxfemurfracturelawsuit.com/side-effects-of-fosamax/ Photo Credits: http://commons.wikimedia.org/wiki/User:Jmh649 http://www.flickr.com/people/37102254@N00
Просмотров: 138 fosamaxblogger
Men are not Immune to Osteoporosis
Read more about Osteoporosis in men at http://www.articlesbase.com/medicine-articles/osteoporosis-may-occur-in-men-5078142.html. More official information about Fosamax Side Effects at http://www.fosamaxfemurfracturelawsuit.com/side-effects-of-fosamax/.
Просмотров: 25 fosamaxblogger
Short and LongTerm Safety of Bisphosphonates - Paul D Miller, MD
Watch the full video online at http://onlinesymposia.com/online-videos/11-rob2008
Просмотров: 40 OnlineSymposia
Symptomatic Bone Lesions in CRPC: More Options for Treatment
Neal D. Shore, MD, FACS, describes the various treatment of prevention of bone lesions. The first agents used in this setting were zoledronic acid and denosumab, which both work as anti-resorptive agents. One concern with these agents is the rare occurrence of osteonecrosis of the jaw. Neither of these agents, though effective in reducing skeletal-related events, has demonstrated survival benefit.
Просмотров: 99 OncLiveTV
Osteo-K contains a 45 mg of MK4, a form of Vitamin K2. The Archives of Internal Medicine confirms that this amount of MK4 may decrease the risk of vertebral fractures by 60%, hip fractures by 71% and all nonvertebral fractures by 81%. This is better than Fosamax without any of the Fosamax side effects.
Просмотров: 2445 NBIHealth
Actos Side Effects | Actos Lawsuit | Actos Bladder Cancer
Actos side effects | Actos lawsuit: Actos, with pioglitazone as its sole ingredient, has been linked to increased risk of bladder cancer. Ennis & Ennis P.A. is offering free nationwide confidential Actos lawsuit consultations for patients who have been diagnosed with cancer while or after taking Actos, Actoplus or Duetact. Call toll free 1-800-856-6405 or by visit www.ennislaw.com and complete an online case evaluation form.
Просмотров: 9216 EnnisLawTV
Day 1 - Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention
More than 10 million people in the United States have osteoporosis, a skeletal disorder that causes bones to become weak and fragile as a result of low bone mass. The condition makes people more susceptible to fractures, which can impair their ability to live independently and even threaten their lives. The social and economic burden of osteoporotic fractures is substantial. Reducing osteoporosis prevalence and hip fracture incidence are among the major objectives of Healthy People 2020, the U.S. Department of Health & Human Services’ national health promotion and disease prevention initiative. Lifestyle changes—including getting adequate nutrition and regular exercise, quitting tobacco use, limiting alcohol use, and preventing falls—can help reduce a person’s risk of osteoporotic fractures. However, medications may be prescribed to prevent fractures if a person has very low bone mineral density or has experienced a prior fragility fracture. The U.S. Food and Drug Administration has approved several types of drugs to prevent osteoporotic fractures. Clinical guidelines by various medical organizations recommend bisphosphonates (BPs) as a first line of treatment for most people who have osteoporosis. BPs are effective for short-term use (up to 3–5 years) by people who are at high risk of fracture. However, the benefits and risks of longer-term treatment are less clear. Reports of rare but serious adverse events such as atypical femoral fractures and osteonecrosis (death of cells) of the jaw have raised questions about the safety of osteoporosis drug use, especially in people who use the drugs for more than 3–5 years or who had a low risk of fracture when they began treatment. Research Challenges There is a gap in scientific data about the appropriate long-term use of many osteoporosis drugs. There are uncertainties about which people will benefit or may be harmed if they take the drugs long-term. Public concern about these and other unanswered questions has coincided with a significant decrease in use of osteoporosis drugs and a leveling off in what had been a promising decline in the incidence of osteoporotic fractures. These changes have raised concerns within medical and professional communities that many people who might need the drugs are not being prescribed them, and those who are prescribed them are not taking them. In addition, evidence is limited regarding the initiation and length of “drug holidays” (a medical practice in which a patient stops taking medications for a period of time and then resumes treatment again, if the patient or their doctor believes it could be in their best interests), whether stopping treatment reduces the risk of serious adverse events while maintaining fracture prevention benefit, and which individuals should change treatments instead of simply taking a drug holiday from their current medication. Innovative research strategies are needed to address these knowledge gaps and to help better inform individuals and physicians in their decision-making about osteoporosis treatment. Workshop Goals This P2P workshop will assess the available scientific evidence to better understand the appropriate use of drugs for osteoporotic fracture prevention, specifically addressing the following questions: What are the benefits and risks (including major adverse events) of osteoporotic drugs with short-term use (from first-use up to 3–5 years of treatment)? What factors influence outcomes? What are the benefits and risks of osteoporotic drugs over the longer term (for treatment periods longer than 3–5 years)? What factors influence outcomes? Do drug holidays improve outcomes? What patient and clinician factors impact the use of and adherence to osteoporotic drugs? Workshop Sponsors National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases NIH Office of Disease Prevention
Просмотров: 134 NIH ODP
Doctor's "scare tactics didn't work" -- Osteo-K Improved Joan's Bone Mineral Density
Joan was diagnosed with osteoporosis and osteopenia. She'd read about the research behind Osteo-K, how it was formulated by physicians from Harvard, Cornell, MIT and Bastyr and wanted to try it. Even though her doctors tried to scare her out of trying it, she was convinced by the research and started taking it. Her bone density improved and she is thrilled by how all natural Osteo-K helped her build stronger bones so she can maintain her active lifestyle. www.nbihealth.com.
Просмотров: 886 NBIHealth